LAG3 and neoplasm: There was only one LAG3-positive tumor (0.8%) with more than 4% LAG3-positive TILs, 29.0% of tumors had low-LAG3-expressing TILs, and 70.2% of tumors showed no LAG3-positive TILs (see Figure 2A).